retatrutide and type 1 diabetes What Does Current Research Suggest About Retatrutide's Role in Glucago – Prime Lab Peptides The Science Behind Retatrutide: A

these effects are greater than those reported for currently approved single or dual agonists 1,3

The main difference is that Zepbound targets two hormones (GLP-1 and GIP) while Saxenda targets only GLP-1, and Zepbound requires weekly injections versus daily shots for Saxenda

10.1007/s00125-022-05748-9

MR = Mendelian randomization

Warnings for GLP-1 Agonists

Excessive appetite suppression can interfere with: Protein sufficiency Post-training nutrition Meal timing consistency Training energy and focus Retatrutides clinical profile suggests robust appetite suppression , which may be appropriate in general obesity contexts but challenging for athletes who must maintain structured eating patterns